Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Ensuring remote diagnostics for pathologists: an open letter to the US Congress

Subjects

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Department of Health & Human Services (HHS), Center for Clinical Standards and Quality/Survey & Certification Group Ref: QSO-20-21-CLIA. Clinical Laboratory Improvement Amendments (CLIA) Laboratory Guidance During COVID-19 Public Health Emergency (March 26, 2020); https://www.cms.gov/files/document/qso-20-21-clia.pdf-0 (accessed 7 September 2022).

  2. Furness, P. N. & Bamford, W. M. Curr. Diagn. Pathol. 7, 281–291 (2001).

    Article  Google Scholar 

  3. Dietz, R. L. et al. Am. J. Clin. Pathol. 153, 198–209 (2020).

    Article  Google Scholar 

  4. HHS. Fiscal Year 2023: Budget in Brief; https://www.hhs.gov/sites/default/files/fy-2023-budget-in-brief.pdf (accessed 7 September 2022).

  5. US Centers for Medicare & Medicaid Services (CMS). Strategic Plan; https://www.cms.gov/ (accessed 7 September 2022).

  6. US Clinical Laboratory Improvement Advisory Committee (CLIAC); https://www.cdc.gov/cliac/index.html (accessed 7 September 2022).

  7. US Center for Clinical Standards and Quality, CMS. Functional Statement; https://www.cms.gov/About-CMS/Agency-Information/CMSLeadership/Office_CCSQ (accessed 7 September 2022).

  8. US Centers for Disease Control. Clinical Laboratory Improvement Amendments (CLIA): CLIA Law and Regulations; https://www.cdc.gov/clia/law-regulations.html (accessed 7 September 2022).

  9. US Statute at Large. 102 Stat. 2903 - Public Law 100-578, 100th Congress; https://www.congress.gov/public-laws/100th-congress (31 October 1988).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jochen K. Lennerz.

Ethics declarations

Competing interests

All authors are members of the Association of Directors of Anatomic and Surgical Pathology. Affiliations and professional organizations are listed for identification purposes. The views expressed in this letter are those of the individual signatories and do not necessarily reflect the views of the affiliated institutions or organizations. L.P. is on the medical advisory board for Ibex, a consultant for Hamamatsu, and equity owner of LeanAP Innovators; G.G.B. completed contracted research for Hamamatsu; J.H. is a consultant for Aadi Bioscience and Tracon Pharmaceuticals; all other authors have no relevant conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lennerz, J.K., Pantanowitz, L., Amin, M.B. et al. Ensuring remote diagnostics for pathologists: an open letter to the US Congress. Nat Med 28, 2453–2455 (2022). https://doi.org/10.1038/s41591-022-02040-6

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41591-022-02040-6

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing